Cargando…

Sepsis-induced lung fibrosis in baboons is reduced by the treatment with a complement inhibitor

Detalles Bibliográficos
Autores principales:	Lupu, F, Zhu, H, Silasi-Mansat, R, Georgescu, C, Popescu, N, Peer, G, Lupu, C, Taylor, F, Kinasewitz, G, Lambris, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239277/ http://dx.doi.org/10.1186/cc10403

Ejemplares similares

Complement inhibition decreases early fibrogenic events in the lung of septic baboons
por: Silasi-Mansat, Robert, et al.
Publicado: (2015)

Pathophysiology, staging and therapy of severe sepsis in baboon models
por: Taylor, Fletcher B, et al.
Publicado: (2012)

Temporal dynamics of gene expression in the lung in a baboon model of E. coli sepsis
por: Zhu, Hua, et al.
Publicado: (2007)

The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis
por: Lupu, Florea, et al.
Publicado: (2020)

Sphingosine 1‐phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons
por: Frej, Cecilia, et al.
Publicado: (2016)

Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus
por: Silasi, Robert, et al.
Publicado: (2021)

The NuRD Chromatin-Remodeling Enzyme CHD4 Promotes Embryonic Vascular Integrity by Transcriptionally Regulating Extracellular Matrix Proteolysis
por: Ingram, Kyle G., et al.
Publicado: (2013)

Treatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon
por: Turpin, Jocelyn, et al.
Publicado: (2015)

Complexity of complement activation in sepsis
por: Markiewski, Maciej M, et al.
Publicado: (2008)

Suppression of Tumor Growth in Mice by Rationally Designed Pseudopeptide Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase()
por: Jackson, Kenneth W., et al.
Publicado: (2015)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Immunoadsorption of lipopolysaccharides, IL-6 and complement-activation product 5a in severe sepsis and septic shock
por: Schefold, J, et al.
Publicado: (2006)

An epidemiological study of sepsis in ICUs: Sepsis Brazil Study
por: Sales, J, et al.
Publicado: (2006)

“Crossroads in Sepsis Research” Review Series Overview of the pathophysiology of sepsis
por: Lupu, Florea
Publicado: (2008)

Role of ADTRP (Androgen‐Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function
por: Patel, Maulin M., et al.
Publicado: (2018)

In vivo detection of c-Met expression in a rat C6 glioma model
por: Towner, RA, et al.
Publicado: (2008)

Dysregulation of immune monocyte responses during sepsis
por: Fiume, D, et al.
Publicado: (2011)

Difficulties in the management of the meningitis with C. neoformans
por: Benea, Elisabeta Otilia, et al.
Publicado: (2014)

Microbiology profile of sepsis in Brazil
por: Goldwasser, R, et al.
Publicado: (2007)

Impact of the Surviving Sepsis Campaign clinical guideline of in sepsis mortality in a public health institution in Brazil
por: de Aguiar, Suellen C, et al.
Publicado: (2013)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Soluble TLT-1 is a naturally occurring TREM-1 inhibitor and protects mice from hyperresponsiveness and death during sepsis
por: Derive, M, et al.
Publicado: (2010)

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, L, et al.
Publicado: (2009)

A proteomic study of sepsis
por: Soares, A, et al.
Publicado: (2005)

Protein C in murine neonatal sepsis
por: Muchitsch, E, et al.
Publicado: (2005)

Sepsis and multiple organ dysfunction in burn
por: Henrich, Sabrina F, et al.
Publicado: (2013)

A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression
por: Footer, BW, et al.
Publicado: (2011)

A novel DDAH-1 inhibitor improved sepsis-induced impairment in vasoreactivity to noradrenaline in a rat endotoxaemia model
por: Wang, Z, et al.
Publicado: (2011)

A novel DDAH-1 inhibitor improved cardiovascular function in a short-term anesthetized rat model of sepsis
por: Wang, Z, et al.
Publicado: (2011)

Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)
por: Patel, JM, et al.
Publicado: (2011)

Severe sepsis and sepsis shock secondary to non ventilator associated nosocomial pneumonia. principal features and predictors of outcome
por: Zaragoza, R, et al.
Publicado: (2015)

Is sepsis mortality rate driven by differences in Brazilian healthcare systems?
por: Machado, F, et al.
Publicado: (2010)

Therapeutic success in a case of anaerobic sepsis with multiple brain abscesses in the context of an efficient interdisciplinary cooperation
por: Drăgoi, Anca Mihaela, et al.
Publicado: (2013)

Myocardial dysfunction in sepsis studied with the pressure recording analytical method
por: Pratesi, F, et al.
Publicado: (2008)

Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis
por: Knoerzer, D, et al.
Publicado: (2013)

Impact of early sepsis on oxygen delivery in the microvasculature
por: Fraser, G, et al.
Publicado: (2005)

Impact of early sepsis on oxygen delivery in the microvasculature
por: Fraser, G, et al.
Publicado: (2006)

Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction
por: Karasu, Ebru, et al.
Publicado: (2019)

Asymmetric and symmetric dimethylarginines: metabolism and role in severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)

Lack of adalimumab's complement dependent cytotoxicity on human cells expressing complement regulatory proteins
por: Grebe, K M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ac8soh88ctfplpj6teurbtor8t